Company: BLTE
Filing Date: 2025-08-07
Form Type: 6-K
Source: 0001104659-25-075001
Chunk: 1

Company: BELITE BIO, INC
Filing Date: 2025-08-07
Form: 6-K
Chunk 1
---
 as the Placement Agent for the Company in connection
with the Offering.

The Offering was made pursuant to the Company’s shelf registration
statement on Form F-3 (File No. 333-284521), which was declared effective on January 27, 2025.

Copies of the form of the Securities Purchase Agreement and the form
of Placement Agency Agreement are attached hereto as Exhibit 1.1 and Exhibit 1.2, respectively, and are incorporated herein by reference.
A copy of the form of warrant is attached hereto as Exhibit 4.1 and is incorporated herein by reference. The foregoing descriptions of
the Securities Purchase Agreement, Placement Agency Agreement and warrants do not purport to be complete and are subject to and qualified
in their entirety by reference to, the Securities Purchase Agreement, the Placement Agency Agreement and form of warrant, which are attached
hereto as Exhibits 1.1, 1.2 and 4.1, respectively, and are incorporated herein by reference.

This Report on Form 6-K shall be deemed to be incorporated by reference
into all effective registration statements filed by the registrant under the Securities Act of 1933, and shall be a part thereof from
the date on which this report is filed, to the extent not superseded by documents or reports subsequently filed or furnished.

<div align='center'>EXHIBIT INDEX</div>

Exhibit 1.1 — Form of Securities Purchase Agreement

Exhibit 1.2 — Form of Placement Agency Agreement

Exhibit 4.1 — Form of Warrant

Exhibit 99.1 — Press Release

<div align='center'>SIGNATURE</div>

Pursuant to the requirements of the Securities Exchange Act of 1934,
the registrant has duly caused this report to be signed on its behalf by the undersigned, thereunto duly authorized.

| Belite Bio, Inc |                                      |
| By:             | /s/ Yu-Hsin Lin                      |
| Name:           | Yu-Hsin Lin                          |
| Title:          | Chief Executive Officer and Chairman |

Date: August 7, 2025